These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37337402)

  • 1. Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy.
    Abe H; Okada-Tsuchioka M; Kajitani N; Omori W; Itagaki K; Shibasaki C; Boku S; Matsuhisa T; Takebayashi M
    Neuropsychopharmacol Rep; 2023 Sep; 43(3):359-364. PubMed ID: 37337402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group box-1 and receptor for advanced glycation end products in preterm infants with brain injury.
    Lu HY; Ma JL; Shan JY; Zhang J; Wang QX; Zhang Q
    World J Pediatr; 2017 Jun; 13(3):228-235. PubMed ID: 27995540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.
    Smit PJ; Guo WA; Davidson BA; Mullan BA; Helinski JD; Knight PR
    J Surg Res; 2014 Sep; 191(1):214-23. PubMed ID: 24814199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
    Basta G; Del Turco S; Navarra T; Lee WM;
    Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Receptors for Advanced Glycation End Products and High-Mobility Group Box 1 in the Outcome of Human T Cell Lymphotropic Type 1 Infection.
    Yaghouti N; Boostani R; Mohamamdi A; Poursina Z; Rezaee SA; Vakili V; Valizadeh N; Shams A; Rafatpanah H
    Viral Immunol; 2019 Mar; 32(2):89-94. PubMed ID: 30585773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE.
    Romero R; Chaiworapongsa T; Savasan ZA; Hussein Y; Dong Z; Kusanovic JP; Kim CJ; Hassan SS
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):558-67. PubMed ID: 22578261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
    Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
    Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated HMGB1 and sRAGE levels in cerebrospinal fluid of aneurysmal subarachnoid hemorrhage patients.
    Chu XH; Hu HY; Godje ISG; Zhu LJ; Zhu JB; Feng YL; Wang H; Zhang YB; Huang J; Sun XG
    J Stroke Cerebrovasc Dis; 2023 May; 32(5):107061. PubMed ID: 36871437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
    Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
    Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
    Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
    J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
    Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
    Front Immunol; 2019; 10():460. PubMed ID: 30923525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury.
    Miyagawa T; Iwata Y; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Kamikawa Y; Miyake T; Kitajima S; Toyama T; Hara A; Sakai N; Shimizu M; Furuichi K; Munesue S; Yamamoto Y; Kaneko S; Wada T
    Biol Open; 2022 Jan; 11(1):. PubMed ID: 34812852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble receptor for advanced glycation end-products and progression of airway disease.
    Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
    BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
    Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
    J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study.
    Zakiyanov O; Kriha V; Vachek J; Zima T; Tesar V; Kalousova M
    BMC Nephrol; 2013 Nov; 14():245. PubMed ID: 24188108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alarmins and Related Molecules in Elective Surgery.
    Strohalmová S; Levová K; Kuběna AA; Hoskovec D; Krška Z; Zima T; Kalousová M
    Folia Biol (Praha); 2023; 69(2):50-58. PubMed ID: 38063001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome.
    Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
    Clin Biochem; 2011 Jun; 44(8-9):601-4. PubMed ID: 21211520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
    Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-high-mobility group box-1 (HMGB1) mediates the apoptosis of alveolar epithelial cells (AEC) by receptor of advanced glycation end-products (RAGE)/c-Jun N-terminal kinase (JNK) pathway in the rats of crush injuries.
    Zhang BF; Song W; Wang J; Wen PF; Zhang YM
    J Orthop Surg Res; 2022 Jan; 17(1):20. PubMed ID: 35033142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.